SmarterDx
Clinical AI that audits charts pre-bill to recover missed diagnoses.
SmarterDx applies clinical AI to audit inpatient charts before billing, surfacing missed diagnoses and clinical evidence for CDI teams to review with a human in the loop.
This page may include affiliate links or demo-request routing. Commercial relationships do not affect HealthAIdir scores, verdicts, rankings, or recommendations.
Introduction
This review has not published a long-form introduction yet.
Pros
- Audits 100% of charts pre-bill
- Integrates with Epic, Cerner, and Meditech in weeks
- Human-in-the-loop keeps CDI teams in control
Cons
- Narrow to inpatient revenue integrity, not full RCM
- Requires an existing CDI team
- Value depends on capture under results-based pricing
Pricing
Pricing summary
Not publicly listed; vendor describes results-based pricing tied to captured revenue.
Compliance review
HIPAA
Confirmed
BAA
Not reviewed
Review CDI governance, coding compliance policy, PHI data flows, BAA terms, audit logs, EHR access, and how human reviewers approve or reject pre-bill findings.
Questions to ask before a demo
Use these questions to turn this profile into a buyer-side evidence checklist. HealthAIdir does not verify production readiness, clinical safety, compliance approval, coding accuracy, billing accuracy, or legal suitability.
- 1
Which healthcare workflow does SmarterDx support best?
Ask the vendor to map supported users, handoffs, review steps, and failure modes to your clinical, revenue cycle, or operations workflow.
- 2
What evidence should be reviewed before a pilot?
Request source documentation, validation notes, customer scope, update history, and implementation assumptions rather than relying on marketing claims.
- 3
How should the compliance and data handling claims be verified?
Confirm PHI flow, BAA availability, privacy terms, security controls, audit logs, subprocessors, and whether claims are contractual or only descriptive.
- 4
What integration and implementation work is required?
Clarify EHR, billing, identity, data export, monitoring, support ownership, training, timeline, and rollback requirements.
- 5
What pricing, contract, and pilot success criteria should be confirmed?
Review pricing unit, minimum commitments, renewal terms, cancellation, support scope, measurable pilot outcomes, and buyer-side responsibilities.
Related research
Continue researching SmarterDx.
Use explicit comparisons and alternative tool profiles to keep shortlist research connected to source evidence.
SmarterDx vs Adonis
Compare SmarterDx with Adonis: AI orchestration platform that monitors revenue cycle data and resolves claims.
SmarterDx vs Candid Health
Compare SmarterDx with Candid Health: RCM automation platform that maximizes first-pass touchless claim rates.
Nym vs SmarterDx
Compare SmarterDx with Nym: Autonomous medical coding with audit-trail emphasis.
CodaMetrix vs SmarterDx
Compare SmarterDx with CodaMetrix: Contextual medical coding automation for provider organizations.
Revenue Cycle
AI tools for medical billing, coding, claims, denials, and revenue cycle workflows.
RCM
Revenue cycle management workflows and automation.
Information
- Reviewed byHealthAIdir Editorial Team
- Websitewww.smarterdx.com
- Published2026/06/09
- Last reviewed2026/06/11
- VerdictConditional
Compliance snapshot
- HIPAAConfirmed
- BAANot reviewed
- Editorial disclosure
HealthAIdir used vendor public materials for this seed profile. No vendor paid for placement, and buyers should verify all compliance, pricing, and implementation claims directly with SmarterDx.
- Editorial boundary
Featured or sponsor placement does not affect HealthAIdir scores, verdicts, comparisons, or editorial recommendations.
Evidence and sources
Evidence links summarize public source material for traceability. They are not medical, billing, security, HIPAA, BAA, or compliance approval.
Official SmarterDx site and $50M funding announcement describe clinical revenue AI auditing charts pre-bill, EHR integration, and human-in-the-loop CDI review.
Updated 83 days ago from a recorded review event (2026/06/11).